argenxglobal
argenx is a global immunology company developing potential therapies for people living with rare auto
From all of the at argenx, we wish everyone a very happy new year!
Conference collaborations, clinical and commercial milestones, patients inviting us into their homes to capture their stories – we love revisiting these 2023 – now here’s to #2024! 🎉
Congratulations December Grads! 🎓 Considering a career in or ? Check out this sneak preview of life at !
You can find all of our here: argenx.com/careers
Life after a generalized diagnosis can be lonely. Tiffany, diagnosed in her twenties, found loneliness, denial, and isolation – but also determination. Discover her inspiring story: https://www.us.argenx.com/node/781533
Home The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels our urgency to deliver them.
It has been an incredible long weekend of collaboration, networking, conversations with peers and more at .
We can’t wait to discover more with our colleagues in 2024!
Swipe through to meet some of the people living with severe autoimmune diseases we’ve had the opportunity to connect with this year – they’ve invited us into their homes, shared their stories, and inspired us every day.
Discover more: https://www.us.argenx.com/newsroom/argenx-stories/patient-stories.
We’re thankful for an eventful year and for the team who got us here – from US, EU, Japan, China, and Canada approvals of our FcRn blocker, positive clinical trial data in new indications, and countless stories of the impact of our work on patients and families.
SeAndra always wanted to be a teacher 🍏 and there was no way she was letting her diagnosis get in the way. Discover more about her support system: https://www.us.argenx.com/node/781529
Home The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels our urgency to deliver them.
It took 6️⃣ years, 3️⃣ primary care physicians, 7️⃣ neurologists, and 8️⃣ misdiagnoses to accurately diagnose Bryan with . Discover more about Bryan’s long road to peace of mind, and his path to recovery: https://www.us.argenx.com/node/781527
Home The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels our urgency to deliver them.
Did you know there are over 90 million family caregivers in the US alone? 🫂
Caregiver Action Network recognizes November as , where we celebrate the immense effort that provide for their loved ones every day – amounting to countless hours of unpaid labor and energy.
Thank you to all who are there for their loved ones .
Discover how to get involved here: https://www.caregiveraction.org/national-family-caregivers-month
Calling the curious and inquisitive! Learn why our scientists – the team constantly asking questions to help people with diseases – explored careers.👇
Favorite part of : The incredible science on display? Or strong coffee? ☕ We asked the Argonauts to share their favorite part of – watch for more!
We enjoyed the MGFA scientific sessions at this morning, exploring recent data that demonstrate the safety and efficacy of our FcRn blocker, as well as important findings in the burden of disease and disparities in care for generalized .
Wondering where to go first at ? Hear our own Matthew Behr share his recommendations.
“I want to be Tom, because that’s who I am.” The road to an diagnosis can be long and hard, but Tom’s tenacity is helping him get back in the driver’s seat of his life.
Discover more: https://www.us.argenx.com/node/781525
Home The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels our urgency to deliver them.
We all have a protein receptor in our bodies called that serves an important role in our immune system. But for people with severe , blocking FcRn might be the key to redefining what it means to live with one of these conditions. Find out how.
Humility is often undervalued in leadership and strategic decision-making. Arjen Lemmen explains why that’s a mistake.
Hear more from Arjen Lemmen, VP of Corporate Development and Strategy.
Carving your own career path is hard enough without the added challenge of living with – but Meredith found a way. Discover how: https://www.us.argenx.com/node/781523
When Career Goals Collide with Myasthenia Gravis Patient Stories When Career Goals Collide with Myasthenia Gravis Twitter Facebook LinkedIn WhatsApp By the time Meridith graduated from college, she had been living with generalized myasthenia gravis (MG) for years. However, entering the workforce presented a new set of challenges that she didn't fo...
FcRn receptors play an important role in the immune system. But what happens when the process of recycling antibodies backfires? And what does that mean for people with severe autoimmune disorders?
What are the building blocks of true ? We asked our own Arjen Lemmen. Watch and learn.
Welcome to Boston for ! 🍀 Don’t miss panels with two of our own fierce leaders:
🧪 Luc Truyen, M.D., Ph.D., Chief Medical Officer, in "Editorial Panel: The Next Blockbuster Indications" at 10:30am ET in Grand Ballroom B-E.
📈 Luis Carlos Sánchez, MBA, MSc, Senior Director of Commercial New Product Planning in “Optimize Your Portfolio and Pipeline Strategies” at 1:30 PM ET in the Marina Ballroom.
Part of the community and wondering how to talk to Spanish-speaking loved ones about your ?
Click through the carousel for how to describe rare autoimmune diseases like , , , and in Spanish.
Part of the community and wondering how to talk to Spanish-speaking loved ones about your ? Click through the carousel for key phrases to answer questions about life with rare autoimmune diseases like gMG, ITP, CIDP, and PV.
Humbled to bring home honors in three different categories at last week’s Trailblazer awards. Thank you to our dedicated teammates and collaborators who innovate across every part of the business for people with severe autoimmune diseases!
🧪 Company of the Year: Specialty Pharma/Biotech
💉 Marketing Team of the Year Gold Winner - VYVGART Brand Launch Team
🏃♀️Trailblazer Brand Champion Award: Autoimmune/Rheumatology – Katrina Sergeev
Discover more: https://www.prnewswire.com/news-releases/pm360-announces-2023-trailblazer-award-winners-301943290.html
How are you prioritizing greater in your own life?
Discover more tips to maintain positive mental health while balancing work, family, and other aspects of life from argenx’ Luis Carlos Sánchez, MBA, MSc, Senior Director of Commercial and Product Planning.
🤝Partnerships are essential in healthcare. But how do companies effectively partner to deliver innovation to people with autoimmune disease?
Our Vice President of Corporate Development & Strategy Arjen Lemmen stepped onto the stage at the BioCentury East-West BioPharma Summit to discuss opportunities to innovate together and extend the reach of your innovation to new patient populations.
Thank you to the moderator, panelists and organizers for the great discussion!
Did you attend the summit? Tell us your thoughts in the comments 👇
Over the last month, our team of Argonauts from across the globe gathered for several employee events donning their purple to show support for the patient community. 💜
The last Friday of September is known as “Sport Purple for Platelets Day” – capping a month of awareness-building and resource sharing for the sake of the patient community. We are committed to learning from and working with the ITP community to meet our goal of improving patient lives.
What brings you to work in ? Rebecca McLeod, our US General Manager, shares her motivation, along with what she wishes more people knew about innovating for the community.
Let’s meet the innovative team working to bring our FcRn blocker to Canadians living with generalized myasthenia gravis! 🇨🇦
“We’d like to dedicate this award to the generalized myasthenia gravis patient community and their loved ones, who inspire us every day.” ⭐
Honored to bring home the BioTech Week Boston award for Transformational Therapy! Thank you Biotech Week Boston for recognizing the depth of Boston-based innovation and its impact on society.
To the community living with like ITP, CIDP, and PV: you are not alone.
We know that talking about symptoms with family can be difficult. This , check out this expanded guide to share with your Spanish-speaking loved ones so they can better understand life with these rare autoimmune diseases.
Click here to claim your Sponsored Listing.
Videos (show all)
Category
Website
Address
33 Arch Street, 32nd Floor Suite 3201
Boston, MA
Boston
Paul is the co-founder and CEO of Mercy Bioanalytic. He began his career in 1986 as an investment banker with Citibank and Donaldson, Lufkin & Jenrette. He then served as the Presi...
139A Charles Street #315
Boston
Our novel family of Janus base nanomaterials is based on DNA nanotechnology.
27 Drydock Avenue
Boston, 02210
A next-generation biosecurity platform, by Ginkgo Bioworks.
Boston, 02210
Clinical-stage rare disease biopharmaceutical company developing novel therapeutics for treatment of abnormal mineralization diseases. We are focused on therapies to treat the rare...
Boston, 02109
At Cora Care, we are developing prognostic tools to help pet owners take care of their pets.
Boston, 02210
Innovating to transform the treatment of devastating diseases through intracellular therapeutics.
99 High Street, 30th Floor
Boston, 02110
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, ...
Boston, 02135
NanoView Biosciences is focused on enabling worldwide life science researchers to better understand the biological role of extracellular vesicles, including exosomes and viral vect...
Boston
Welcome to Pronova, we are here to help you care for your pets by pioneering a new standard of care.
121 Seaport Boulevard
Boston, 02210
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to ...